| Literature DB >> 27812616 |
Sanrrangers Sales Silva1, Maximilo de Oliveira Ribeiro2, Francisco Isaac Fernandes Gomes1, Hellíada Vasconcelos Chaves1, Antonio Alfredo Rodrigues E Silva3, Iriana Carla Junqueira Zanin1, Francisco Cesar Barroso Barbosa1.
Abstract
OBJECTIVE: : To determine the occurrence and the in vitro antimicrobial susceptibility of enteric rods and pseudomonads from the denture biofilm of 52 subjects at the Center for Dental Specialties of Sobral/ Ceara, Brazil.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27812616 PMCID: PMC5083023 DOI: 10.1590/1678-775720160032
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Age and gender distribution of subjects in the 2007-2008 period
| AGE | MEN | WOMEN | TOTAL | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| 35-49 | 0 | 00.0 | 4 | 9.5 | 4 | 9.5 |
| 50-64 | 3 | 30.0 | 19 | 45.2 | 22 | 42.3 |
| 65-79 | 5 | 50.0 | 17 | 40.5 | 22 | 42.3 |
| >80 | 2 | 20.0 | 2 | 4.8 | 4 | 7.7 |
| Total | 10 | 19.2 | 42 | 80.5 | 52 | 100 |
Bacterial species distribution isolated from dental prostheses biofilm
| MICROORGANISM | MEN | WOMEN | ||
|---|---|---|---|---|
| n | % | n | % | |
| Only | 6 | 60.0 | 24 | 57.1 |
| Only | 0 | 00.0 | 1 | 2.4 |
|
| 0 | 00.0 | 1 | 2.4 |
| Other species of microrganisms | 0 | 00.0 | 2 | 4.8 |
| Absence of microrganisms | 4 | 40.0 | 14 | 33.3 |
| Total of individuals | 10 | 100.0 | 42 | 100.0 |
Number of analyzed subjects with dental prostheses harboring enteric rods, Pseudomonas, Acinetobacter spp., and Burkholderia spp. associated with groups of age and gender
| AGE | MEN | WOMEN | TOTAL | |||
|---|---|---|---|---|---|---|
| h/n | h% | h/n | h% | h/n | h% | |
| 35-49 | 0/0 | 0.0 | 3/4 | 75.0 | 3/4 | 75.0 |
| 50-64 | 2/3 | 66.7 | 11/19 | 57.9 | 13/22 | 59.1 |
| 65-79 | 3/5 | 60.0 | 12/17 | 70.6 | 15/22 | 68.2 |
| ≥80 | 1/2 | 50.0 | 2/2 | 100.0 | 3/4 | 75.0 |
| All ages | 6/10 | 60.0 | 28/42 | 66.7 | 34/52 | 65.4 |
n= subjects in each group
h= harboring subjects in each group
h%= percentage of harboring subjects
Number of subjects wearing harbored or non-harbored dental prostheses by enteric rods, Pseudomonas, Acinetobacter spp., and Burkholderia spp. associated for time of dental prostheses usage
| TIME OF USAGE (YEARS) | CONTAMINATED | CONTAMINATED | ||
|---|---|---|---|---|
| h/n | h% | nh/ n | nh% | |
| 0-10 | 19/32 | 59.4 | 13/32 | 40.6 |
| 11-20 | 11/13 | 84.6 | 2/13 | 15.4 |
| 21-30 | 4/6 | 66.6 | 2/6 | 33.4 |
| 31-40 | 0/1 | 0.0 | 1/1 | 100.0 |
n= subjects in each group
h= harboring subjects in each group
h%= percentage of harboring subjects
nh= non-harboring subjects in each group
nh%= percentage of non-harboring subjects
Antimicrobial susceptibility of microorganisms isolated from denture biofilms
| Microorganism | CIP | IPM | TET | CTX | AMO | DOX | AMC | TOB |
|---|---|---|---|---|---|---|---|---|
|
| S(9) | S(9) | S(3)I(1) R(5) | S(7)I(1) R(1) | R(9) | S(4)I(3) R(2) | S(4)I(1) R(4) | S(8)R(1) |
|
| S(8) | S(7)R(1) | S(5)R(3) | S(6)R(2) | S(3)R(5) | S(6)I(1) R(1) | S(3)I(1) R(4) | S(7)R(1) |
|
| S(8) | S(8) | S(6)R(2) | S(7)I(1) | R(8) | S(6)R(2) | R(8) | S(8) |
|
| S(4) | S(4) | S(3)R(1) | S(2)I(1) R(1) | I(1)R(3) | S(2)I(1) R(1) | S(1)I(2) R(1) | S(4) |
|
| S(4) | S(4) | S(4) | S(4) | S(1)R(3) | S(4) | S(4) | S(4) |
|
| S(3) | S(3) | S(3) | S(2)R(1) | R(3) | S(3) | S(2)R(1) | S(3) |
|
| S(3) | S(3) | I(1)R(2) | S(1)I(1) R(1) | R(3) | S(1)R(2) | I(1)R(2) | S(2)R(1) |
|
| S(3) | S(3) | S(2)R(1) | S(2)I(1) | S(1)R(2) | S(3) | S(1)R(2) | S(2)R(1) |
|
| S(2) | S(2) | I(2) | I(1)R(1) | R(2) | S(1)R(1) | R(2) | S(2) |
|
| S(2) | S(2) | S(1)I(1) | S(1)I(1) | R(2) | S(1)R(1) | R(2) | S(2) |
|
| S(2) | S(2) | I(1)R(1) | S(1)I(1) | R(2) | R(2) | R(2) | S(2) |
|
| S(1) | S(1) | I(1) | I(1) | R(1) | R(1) | R(1) | S(1) |
|
| S(1) | S(1) | S(1) | S(1) | R(1) | S(1) | R(1) | S(1) |
|
| S(1) | S(1) | R(1) | I(1) | R(1) | R(1) | R(1) | S(1) |
|
| S(1) | S(1) | S(1) | S(1) | S(1) | S(1) | S(1) | S(1) |
S= sensible; I= intermediate sensibility; R= resistant
Susceptibilities values (μg/mL) were analyzed according to the Clinical and Laboratory Standards Institute CLSI (2015): CIP (Ciprofloxacin): R=≤15; 1=16-20; S=≥21; IPM (Imipenem): R=≤13; 1=14-15; S=≥16; TET (Tetracycline): R=≤14; 1=15-18; S=≥19; CTX (Cefotaxime): R=≤14; 1=15-22; S=≥23; DOX (Doxycycline): R=≤12; 1=13-15; S=≥16; AMC (amoxicillin + clavulanic acid): R=≤13; 1=14-17; S=≥18; TOB (Tobramycin): R=≤12; 1=13-14; S=≥15; AMO (Amoxicillin): R=≤13; 1=14-16; S=≥17
Percentage of susceptibility of multiresistant microbial species isolated from dental prostheses biofilm regarding Minimum Inhibitory Concentration (MIC) of five antibiotics tested
| Microorganism(n) | CT | TM | DC | IP | CI |
|---|---|---|---|---|---|
|
| |||||
| Sensible | 66.6 | 88.9 | 77.8 | 77.8 | 79.8 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0% | 11.1 | 11.1 |
| Resistent | 33.4 | 11.1 | 22.2 | 11.1 | 11.1 |
|
| |||||
| Sensible | 87.5 | 87.5 | 37.5 | 100.0 | 100.0 |
| Intermediate sensibility | 12.5 | 0.0 | 25.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 12.5 | 37.5 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 87.5 | 75.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 15.5 | 0.0 | 0.0 |
| Resistent | 0.0 | 12.5 | 12.5 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 100.0 | 75.0 | 75.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 0.0 | 25.0 | 25.0 | 0.0 |
|
| |||||
| Sensible | 0.0 | 0.0 | 100.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 100.0 | 100.0 | 0.0 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 100.0 | 66.7 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 0.0 | 33.3 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 100.0 | 0.0 | 50.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 0.0 | 100.0 | 50.0 | 0.0 |
|
| |||||
| Sensible | 0.0 | 100.0 | 0.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 |
| Resistent | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
| |||||
| Sensible | 50.0 | 100.0 | 50.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 50.0 | 0.0 | 0.0 |
| Resistent | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
| |||||
| Sensible | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Intermediate sensibility | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Resistent | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
CT (0.002-32 μg/mL), TM (0.016-256 μg/mL), DC (0.016-256 μg/mL), IP (0.002-32 μg/mL), CI (0.002-32 μg/mL); Susceptibilities values (μg/mL) were analyzed according to the Clinical and Laboratory Standards Institute CLSI (2015): Cefotaxime (CT) S≤8, 16≤l≤32, R≥64; Tobramycin (TM) S≤4, l=8, R≥16; Doxicyclin (DC) S≤4, l=8, R≥16; Imipenem (IP) S≤4, l=8, R≥16; Ciprofloxacin (CI) S≤1, l=2, R≥4
Minimum Inhibitory Concentration (MIC) values of five antibiotics* tested for multiresistant microbial species isolated from dental prostheses biofilm
| Microorganism | CT | TM | DC | IP | CI |
|---|---|---|---|---|---|
|
| >32 | 12 | 0.19 | 0.75 | 0.25 |
|
| 0.094 | 2 | 2 | >32 | 0.047 |
|
| 0.5 | 2 | 2 | 0.38 | 0.032 |
|
| 0.047 | 3 | 2 | 0.25 | 0.064 |
|
| 0.064 | 3 | 2 | 0.25 | 0.064 |
|
| 0.032 | 3 | 48 | 0.19 | 0.047 |
|
| >32 | 3 | 16 | 6 | 3 |
|
| >32 | 3 | 2 | 0.25 | 12 |
|
| 0.032 | 3 | 2 | 0.25 | 0.064 |
|
| 0.38 | 16 | 6 | 0.38 | 0.064 |
|
| 0.25 | 1.5 | 3 | 0.38 | 0.064 |
|
| 0.125 | 3 | 12 | 0.25 | 0.023 |
|
| 12 | 0.75 | 32 | 1.5 | 0.125 |
|
| 0.047 | 2 | 1.5 | 0.125 | 0.023 |
|
| 0.064 | 3 | 6 | 0.19 | 0.094 |
|
| 0.125 | 2 | 0.5 | 0.125 | 0.016 |
|
| 2 | 2 | 12 | 0.19 | 0.047 |
|
| 0.25 | 24 | 6 | 0.38 | 1 |
|
| 0.25 | 2 | 3 | 0.38 | 0.064 |
|
| 0.032 | 3 | 3 | 0.25 | 0.047 |
|
| 0.25 | 3 | >256 | 0.38 | 0.064 |
|
| 0.047 | 2 | 2 | 0.19 | 0.047 |
|
| 0.016 | 0.75 | 1.5 | 3 | 0.064 |
|
| 8 | 2 | 2 | 0.25 | 0.064 |
|
| 0.19 | 3 | 2 | 0.25 | 0.047 |
|
| 0.25 | 3 | >256.0 | 0.25 | 0.032 |
|
| 0.25 | 3 | 3 | >32 | 0.047 |
|
| 0.094 | 2 | 3 | 0.25 | 0.047 |
|
| 0.25 | 3 | 3 | 0.25 | 0.047 |
|
| 3 | 64 | 0.5 | 0.5 | 0.75 |
|
| 0.064 | 0.75 | 3 | 0.19 | 0.012 |
|
| 3 | 0.75 | 24 | 0.19 | 0.032 |
|
| 0.38 | 2 | 3 | 0.38 | 0.023 |
|
| 3 | 0.5 | 16 | 0.38 | 0.047 |
|
| 8 | 2 | >256 | >32 | 0.5 |
|
| >32 | 1 | 6 | 0.5 | 0.047 |
|
| >32 | 1 | 8 | 0.38 | 0.064 |
|
| 8 | 1 | 1.5 | 1.5 | 0.047 |
|
| 0.5 | 0.023 | 0.25 | 0.032 | 0.047 |
|
| 2 | 0.5 | 3 | 0.19 | 0.003 |
|
| |||||
CT (0.002-32 μg/mL), TM (0.016-256 μg/mL), DC (0.016-256 μg/mL), IP (0.002-32 μg/mL), CI (0.002-32 μg/mL)
μg/mL